The S-Methyl-(2-Methoxycarbonylamino-Benzimidazole-5) Thiosulfonate as Potential Anticancer Agents

Lubenets Vð†, Parashchyn ZhD, Vasylyuk Sv and Novikov Vp
Additional contact information
Novikov Vp: Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology, Ukraine

Global Journal of Pharmacy & Pharmaceutical Sciences, 2017, vol. 3, issue 2, 27-29

Abstract: In-vitro anticancer activity of the S-methyl-(2-methoxycarbonylamino-benzimidazole-5) thiosulfonate (NSC NCI code - 713598 - J/1) was tested by the National Cancer Institute and it has revealed the anticancer activity on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate and breast cancers cell lines.

Keywords: juniper publishers:Journal of Pharmacy; Global Journal of Pharmacy; Pharmaceutical Sciences; Pharmacy & Pharmaceutical Sciences; pharmaceutical sciences journals; omics online; open access; drug discovery; Clinical Trials; juniper publishers open access journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555607.pdf (application/pdf)
https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555607.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjpps:v:3:y:2017:i:2:p:27-29

DOI: 10.19080/GJPPS.2017.03.555607

Access Statistics for this article

Global Journal of Pharmacy & Pharmaceutical Sciences is currently edited by Sophia Mathis

More articles in Global Journal of Pharmacy & Pharmaceutical Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().